Revolution Medicines, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC RVMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

349,412

Value ($000)

27,831

Weight

0.0%

2020 Q3 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	27,831	0.0%	349,412	12/31/2025
2025 Q3	11/14/2025	15,942	0.0%	341,367	9/30/2025
2025 Q2	8/14/2025	18,421	0.0%	500,697	6/30/2025
2025 Q1	5/19/2025	10,615	0.0%	300,196	3/31/2025
2024 Q4	2/14/2025	11,497	0.0%	262,851	12/31/2024
2024 Q3	11/14/2024	9,797	0.0%	216,026	9/30/2024
2024 Q2	8/14/2024	9,371	0.0%	241,447	6/30/2024
2024 Q1	5/15/2024	4,292	0.0%	133,174	3/31/2024
2023 Q4	2/14/2024	3,819	0.0%	133,174	12/31/2023
2023 Q3	11/13/2023	2,885	0.0%	104,238	9/30/2023
2023 Q2	8/11/2023	1,956	0.0%	90,325	6/30/2023
2023 Q1	5/15/2023	1,956	0.0%	90,325	3/31/2023
2022 Q4	2/14/2023	1,498	0.0%	62,901	12/31/2022
2022 Q3	11/14/2022	868	0.0%	43,991	9/30/2022
2022 Q2	8/12/2022	848	0.0%	43,530	6/30/2022
2022 Q1	5/16/2022	1,468	0.0%	57,538	3/31/2022
2021 Q4	2/14/2022	1,027	0.0%	40,814	12/31/2021
2021 Q3	11/15/2021	1,068	0.0%	38,832	9/30/2021
2021 Q2	8/16/2021	1,221	0.0%	38,460	6/30/2021
2021 Q1	5/14/2021	1,023	0.0%	22,300	3/31/2021
2020 Q4	3/1/2021	983	0.0%	24,829	12/31/2020
2020 Q3	11/13/2020	247	0.0%	7,100	9/30/2020